title: Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients.
abstract: Contrast-induced nephropathy (CIN) is a complex syndrome of acute kidney injury that follows exposure to intravascular contrast media. Although a series of preventive measures have been developed, CIN remains a major challenge encountered in elderly patients by interventional cardiologists. No data are currently available concerning the potential effects of the combined use of hydration and alprostadil in the prevention of CIN following percutaneous coronary intervention (PCI) in elderly patients. Therefore, the aim of the present study was to investigate the ability of a combination of hydration and alprostadil to prevent CIN following PCI in elderly patients. From June 1, 2010 to January 31, 2012, 85 elderly patients undergoing PCI were included in the present study. The included patients were randomly allocated into three groups: the control (22 cases), hydration (28 cases) and hydration + alprostadil (35 cases) group. Serum creatinine (SCr) levels were measured prior to PCI and then daily for 3 days following PCI. Creatinine clearance (Ccr) was also calculated. Following investigation of the incidence of CIN, a significant decline in Ccr was observed in the control group but not in the hydration + alprostadil group after PCI. The reduction in the level of Ccr from baseline in the hydration + alprostadil group was the smallest among the three groups. Moreover, the highest incidence of CIN was in the control group (6 cases, 27.27%), followed by the hydration group (3 cases, 10.71%) and the hydration + alprostadil group (1 case, 2.86%). Therefore, the combined use of hydration and alprostadil significantly reduces the incidence of CIN in elderly patients undergoing PCI. Hydration and alprostadil are suggested to act synergistically to protect renal function. In conclusion, the combined use of hydration and alprostadil is more effective in the prevention of CIN in elderly patients undergoing PCI compared with hydration alone.
authors.affiliation: Department of Cardiology, Affiliated Shantou Hospital of Sun Yat-sen University, Shantou, Guangdong 515031, P.R. China.
authors.forename: Rong-He
authors.initials: RH
authors.lastname: Xu
authors.forename: Gui-Zhou
authors.initials: GZ
authors.lastname: Ma
authors.forename: Zhi-Xiong
authors.initials: ZX
authors.lastname: Cai
authors.forename: Ping
authors.initials: P
authors.lastname: Chen
authors.forename: Zhi-Dan
authors.initials: ZD
authors.lastname: Zhu
authors.forename: Wen-Liang
authors.initials: WL
authors.lastname: Wang
keywords: alprostadil; contrast-induced nephropathy; elderly patient; percutaneous coronary intervention